More articles from Systemic Lupus Erythematosus

You have access
Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus Erythematosus
Wietske M. Lambers, Johanna Westra, Hendrika Bootsma and Karina de Leeuw

The Journal of Rheumatology June 1 2021, 48 (6) 847-851; DOI: https://doi.org/10.3899/jrheum.200726
You have access
Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients With Systemic Lupus Erythematosus
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim, Jeong I. Yang, Dong W. Kwak and Chang-Hee Suh

The Journal of Rheumatology May 1 2021, 48 (5) 707-716; DOI: https://doi.org/10.3899/jrheum.200802
You have access
Imaging Pattern and Outcome of Stroke in Patients With Systemic Lupus Erythematosus: A Case-control Study
Lap Kiu Tsoi, Chi Chiu Mok, Bik Ling Man and Yat Pang Fu

The Journal of Rheumatology April 1 2021, 48 (4) 533-540; DOI: https://doi.org/10.3899/jrheum.200664
You have access
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia, Maria G. Tektonidou, Amaia Ugarte, Cecilia B. Chighizola, H. Michael Belmont, Chary Lopez-Pedrera, Lanlan Ji, Paul Fortin, Maria Efthymiou, Guilherme Ramires de Jesus, D. Ware Branch, Cecilia Nalli, Michelle Petri, Esther Rodriguez, Ricard Cervera, Jason S. Knight, Tatsuya Atsumi, Rohan Willis, Maria Laura Bertolaccini, Hannah Cohen, Jacob Rand, Doruk Erkan and on behalf of APS ACTION+

The Journal of Rheumatology April 1 2021, 48 (4) 541-547; DOI: https://doi.org/10.3899/jrheum.200513
Open Access
Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States
Irene B. Murimi-Worstell, Dora H. Lin, Hong Kan, Jonothan Tierce, Xia Wang, Henk Nab, Barnabas Desta, G. Caleb Alexander and Edward R. Hammond

The Journal of Rheumatology March 1 2021, 48 (3) 385-393; DOI: https://doi.org/10.3899/jrheum.191187
You have access
Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis
Michelle Petri, Erik Barr and Laurence S. Magder

The Journal of Rheumatology February 1 2021, 48 (2) 222-227; DOI: https://doi.org/10.3899/jrheum.191094
Open Access
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su and Murray B. Urowitz

The Journal of Rheumatology February 1 2021, 48 (2) 228-231; DOI: https://doi.org/10.3899/jrheum.200161
Open Access
Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST)
Tsutomu Takeuchi, Naoko Wakasugi, Satoshi Uno and Hirofumi Makino

The Journal of Rheumatology January 1 2021, 48 (1) 74-81; DOI: https://doi.org/10.3899/jrheum.191008
Open Access
Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort
Murray B. Urowitz, Dafna D. Gladman, Dominique Ibañez, Jiandong Su, Sara Mursleen, Amyn Sayani, Jorge Alfonso Ross Terres and Sandra Iczkovitz

The Journal of Rheumatology January 1 2021, 48 (1) 67-73; DOI: https://doi.org/10.3899/jrheum.190259
You have access
Antinuclear Antibodies Testing Method Variability: A Survey of Participants in the College of American Pathologists’ Proficiency Testing Program
Stanley J. Naides, Jonathan R. Genzen, Gyorgy Abel, Christine Bashleben and M. Qasim Ansari

The Journal of Rheumatology December 1 2020, 47 (12) 1768-1773; DOI: https://doi.org/10.3899/jrheum.190933

Main menu

User menu

Search

More articles from Systemic Lupus Erythematosus

Pages

Content

Resources

Subscribers

More